To determine whether acetaldehyde toxicity to olaparib‐resistant cells can be recapitulated in vivo, we established tumor allografts from Brca1+/+, Brca1−/−, and PARP inhibitor‐resistant Brca1−/−, 53BP1‐deficient mouse mammary tumor cells. This evidence concerns the gene TP53BP1 and breast cancer.